Inactivation of Herpes Simplex Virus Ribonucleotide Reductase by Subunit Association Inhibitors: A Potential Antiviral Strategy-Reference-Cited by-同舟云学术

Inactivation of Herpes Simplex Virus Ribonucleotide Reductase by Subunit Association Inhibitors: A Potential Antiviral Strategy

Published:1993 Issue: Volume: Page:225-238
ISSN:
Container-title:The Search for Antiviral Drugs
language:
Short-container-title:

Author:

Liuzzi Michel,Déziel Robert

Publisher

Birkhäuser Boston

Link

http://link.springer.com/content/pdf/10.1007/978-1-4899-6718-3_10

Reference44 articles.

1. Adams J, Beaulieu PL, Déziel R, DiMaio J, Grenier L, Lavallée P, Moss N (1991): Antiherpes pentapeptide derivatives having a substituted aspartic acid side chain. Eur Pat App 411,334.

2. Baer R, Bankier AT, Biggin MD, Deininger PL, Farewell PJ, Gibson TJ, Hatfull G, Hudson GS, Satchwell SC, Séguin C, Tuffnell PS, Barrell BG (1984): DNA sequence and expression of the 895-8 Epstein-Barr virus genome. Nature (London) 310:207–211.

3. Bollinger JM, Edmondson DE, Huynh BH, Filley J, Norton JR, Stubbe J (1991): Mechanism of assembly of the tyrosyl radica1-dinuclear iron cluster cofactor of ribonucleotide reductase. Science 253:292–298.

4. Brandt CR, Kintner RT, Visalli RJ, Pumfrey AM, Grau DR (1991): The herpes simplex virus ribonucleotide reductase is required for ocular virulence. J Gen Virol 72:2043–2049.

5. Bushweiler JH, Bartlett PA (1991): Investigation of an octapeptide inhibitor of Escherichia coli ribonucleotide reductase by transferred nuclear Overhauser effect spectroscopy. Biochemistry 30:8144–8151.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peptides as Leads for Drug Discovery;Peptide Drug Discovery and Development;2011-10-17

2. The critical C-terminus of the small subunit of herpes simplex virus ribonucleotide reductase is mobile and conformationally similar to C-terminal peptides;International Journal of Peptide and Protein Research;2009-01-12

3. Emerging therapeutic targets in antiviral and anticancer therapy: a role for ribonucleotide reductase;Emerging Therapeutic Targets;1999-06

4. Antiviral Activity of a Selective Ribonucleotide Reductase Inhibitor against Acyclovir-Resistant Herpes Simplex Virus Type 1 In Vivo;Antimicrobial Agents and Chemotherapy;1998-07

5. Resistance of herpes simplex virus type 1 to peptidomimetic ribonucleotide reductase inhibitors: selection and characterization of mutant isolates;Journal of Virology;1996-02